188 participants
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-08
- Start Date:
- 2021-04-27
- Completion:
- 2029-06-30
Conditions
- Recurrent Head and Neck Squamous Cell Carcinoma
- Recurrent Hypopharyngeal Squamous Cell Carcinoma
- Recurrent Laryngeal Squamous Cell Carcinoma
- Recurrent Oral Cavity Squamous Cell Carcinoma
- Recurrent Oropharyngeal Squamous Cell Carcinoma
Interventions
- DRUG
- PROCEDURE
- RADIATION
- BIOLOGICAL
No Results Yet